INVO Fertility, Inc. Selling and Marketing Expense
INVO Fertility, Inc. (IVF) reported Selling and Marketing Expense of $12.97 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2025-05-20
- INVO Fertility, Inc. selling and marketing expense for the quarter ending 2025-03-31 was $12.97K, a 70.51% increase year-over-year.
- INVO Fertility, Inc. selling and marketing expense for the quarter ending 2024-03-31 was $7.61K.
- INVO Fertility, Inc. selling and marketing expense for fiscal 2024 was $37.46K, a 24.51% increase from fiscal 2023.
- INVO Fertility, Inc. selling and marketing expense for fiscal 2023 was $30.08K.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 12 month |
|---|---|---|
| 2025-03-31 | $12.97K 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $37.46K 10-K · filed 2025-04-30 | |
| 2024-03-31 | $7.61K 10-Q · filed 2025-05-20 | |
| 2023-12-31 | $30.08K 10-K · filed 2025-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |